Delivery Order 75N95019D00037-75N95019F00088
Award Date 9/25/19
Potential Completion Date 9/24/21
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Plainsboro Township, NJ 08536, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The delivery order, valued at $0.00 with a period of performance from September 25, 2019 through May 23, 2022, was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health. Under the delivery order, Xenobiotic Laboratories Inc.'s Biotesting Division...
- This task order was awarded under the Analytical Services Center for Medications Development Program indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute on Drug Abuse to Xenobiotic Laboratories Inc.'s Biotesting Division. The $0 task order provides administrative support services for the Analytical Services Center for Medications Development Program, which aims to develop new medications for substance use disorders. Performance will take...
- Xenobiotic Laboratories Inc. Biotesting Division was awarded a $71,740 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to assess the cytochrome P450 (CYP450) enzyme induction potential of two test articles. Performance will take place in Plainsboro Township, New Jersey from August 2023 through March 2024. The award is in response to a solicitation requesting evaluation of the test...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $109,392.00 contract is for compound testing services, including plasma protein binding studies, PXR and AhR activation studies, and CYP inhibition assays on various small molecule compounds. This work supports NIDA's mission to seek fundamental...
- This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to National Medical Services, Inc. (NMS Labs), a for-profit organization. The $100,333 delivery order is for "NEUROBIOBANK: TOXICOLOGY TESTING" services to support neurobiological and mental health research. NMS Labs, which has over 50 years of experience in clinical and forensic laboratory services, was awarded this task order...
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $70,000 firm fixed price delivery order contract to National Medical Services, Inc., doing business as NMS Labs, located in Horsham, Pennsylvania. The contract is for national medical services to support the agency's mission and is expected to be completed by June 30, 2020. No set-aside provisions were applied to this award made under an unspecified multiple award contract...
- This $249,995 firm fixed-price delivery order was awarded by the National Institutes of Health's National Institute on Drug Abuse to National Medical Services, Inc., doing business as NMS Labs, for unspecified services. As a leading toxicology lab, NMS will likely provide drug testing and analysis to support NIH/NIDA's research efforts. The single base year runs from January 2020 through December 2024 in Horsham, Pennsylvania, with no set-aside designation or named subcontractors. NMS has...
- This is a $119,517.45 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to AB SCIEX LLC. The award does not have a set-aside designation. AB SCIEX LLC, a division of Danaher Corporation, is a provider of mass spectrometry systems, software, consumables, and services to government, commercial, and academic laboratories. Under this contract, AB SCIEX LLC will provide liquid...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...